0001562180-18-004909.txt : 20181211
0001562180-18-004909.hdr.sgml : 20181211
20181211172533
ACCESSION NUMBER: 0001562180-18-004909
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181207
FILED AS OF DATE: 20181211
DATE AS OF CHANGE: 20181211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: IGUCHI KIMI
CENTRAL INDEX KEY: 0001304815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 181229550
MAIL ADDRESS:
STREET 1: 100 FOXBOROUGH BOULEVARD
STREET 2: SUITE 240
CITY: FOXBOROUGH
STATE: MA
ZIP: 02035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-12-07
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001304815
IGUCHI KIMI
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
CFO & Treasurer
Stock Option (Right to Buy)
47.70
2018-12-07
4
A
false
7425.00
0.00
A
2027-02-06
Common Stock
7425.00
7425.00
D
On February 6, 2017, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on December 7, 2018, resulting in the vesting of the option as to 7,425 shares.
/s/ Anne Marie Cook, as Attorney-in-Fact for Kimi Iguchi
2018-12-11